Other Stories

Full Video

S. Korea expands eligibility of oral COVID-19 pills Updated: 2022-05-16 05:42:04 KST

South Korean health authorities have expanded eligibility for oral COVID-19 antiviral drugs.
The Central Disaster Management Headquarters says that, from Monday, Pfizer's Paxlovid will be used for adults or children 12 years or older with a high risk of developing a severe case due to factors, such as underlying diseases.
It added Lagevrio, the second oral pill approved to treat COVID-19 patients in Korea, will be used for adults with underlying medical conditions.
Previously, these drugs were only given to senior citizens over 60, or those over 40 with underlying illnesses.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.